Abstract:Malignant brain tumors, a heterogeneous group of primary and metastatic neoplasms in the central nervous system (CNS), are notorious for their highly invasive and devastating characteristics, dismal prognosis and low survival rate. Recently, near-infrared (NIR) optical imaging modalities including fluorescence imaging (FLI) and photoacoustic imaging (PAI) have displayed bright prospect in innovation of brain tumor diagnoses, due to their merits, like noninvasiveness, high spatiotemporal resolution, good sensitivity and large penetration depth. Importantly, these imaging techniques have been widely used to vividly guide diverse brain tumor therapies in a real-time manner with high accuracy and efficiency. Herein, we provide a systematic summary of the state-of-the-art NIR contrast agents (CAs) for brain tumors single-modal imaging (e.g., FLI and PAI), dual-modal imaging (e.g., FLI/PAI, FLI/magnetic resonance imaging (MRI) and PAI/MRI) and triple-modal imaging (e.g., MRI/FLI/PAI and MRI/PAI/computed tomography (CT) imaging). In addition, we update the most recent progress on the NIR optical imaging-guided therapies, like single-modal (e.g., photothermal therapy (PTT), chemotherapy, surgery, photodynamic therapy (PDT), gene therapy and gas therapy), dual-modal (e.g., PTT/chemotherapy, PTT/surgery, PTT/PDT, PDT/chemotherapy, PTT/chemodynamic therapy (CDT) and PTT/gene therapy) and triple-modal (e.g., PTT/PDT/chemotherapy, PTT/PDT/surgery, PTT/PDT/gene therapy and PTT/gene/chemotherapy). Finally, we discuss the opportunities and challenges of the CAs and nanotheranostics for future clinic translation.

Application of multi-modal and multi-functional molecular imaging based on near-infrared fluorescence dye in tumor models

Multiplexed Imaging with Coordination Nanoparticles for Cancer Diagnosis and Therapy

Novel Dual-Function Near-Infrared II Fluorescence and PET Probe for Tumor Delineation and Image-Guided Surgery.

Molecularly Near-Infrared Fluorescent Theranostics for in Vivo Tracking Tumor-Specific Chemotherapy

Application of near-infrared dyes for tumor imaging, photothermal, and photodynamic therapies.

NIR-I Dye-Based Probe: A New Window for Bimodal Tumor Theranostics

Multifunctional nanotheranostics for near infrared optical imaging-guided treatment of brain tumors

Multifunctional Small Molecule Fluorophore for Long‐Duration Tumor‐Targeted Monitoring and Dual Modal Phototherapy

Multifunctional molecular theranostic agent for fluorescence-magnetic resonance dual-modal imaging and photodynamic-chemodynamic synergistic therapy

A Bimodal MRI and NIR Liposome Nanoprobe for Tumor Targeted Molecular Imaging.

Recent Progress on Molecularly Near-Infrared Fluorescent Probes for Chemotherapy and Phototherapy

Near-infrared fluorescent probe, multi-modal nano contrast agent based on near-infrared fluorescent probe, and preparation and application thereof

Multicolor Two-Photon Nanosystem for Multiplexed Intracellular Imaging and Targeted Cancer Therapy

Near-infrared small molecule coupled with rigidness and flexibility for high-performance multimodal imaging-guided photodynamic and photothermal synergistic therapy

Advance of Molecular Imaging Technology and Targeted Imaging Agent in Imaging and Therapy

Multifunctional Magnetic Nanoparticles for Simultaneous Cancer Near-Infrared Imaging and Targeting Photodynamic Therapy

Advances of Upconversion Nanoparticles for Molecular Imaging

Hierarchically Nanostructured Hybrid Platform for Tumor Delineation and Image-Guided Surgery Via NIR-II Fluorescence and PET Bimodal Imaging.

PET/NIR Fluorescence Bimodal Imaging for Targeted Tumor Detection

Dual receptor NIR-II organic nanoparticles for multimodal imaging guided tumor photothermal therapy

A Multifunctional Nanomicelle for Real‐Time Targeted Imaging and Precise Near‐Infrared Cancer Therapy